EMC Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

EMC Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-208,733	Closed	-$647K	–	358
2021 Q4	$647K	Hold	208,733	–	–	0.35%	67
2021 Q3	$852K	Hold	208,733	–	–	0.48%	56
2021 Q2	$747K	Buy	208,733 +14,827	+8%	+$52.3K	0.42%	68
2021 Q1	$758K	Buy	193,906 +94,973	+96%	+$392K	0.54%	63
2020 Q4	$416K	Buy	+98,933	New	+$381K	0.32%	77

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

EMC Capital Management's BDSI Position: Q1 2022 in Review

EMC Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 208,733 shares — an estimated $647K sold.

EMC Capital Management first reported a position in BDSI in Q4 2020 and held it in 5 quarters. The position peaked at $852K in Q3 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

EMC Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
EMC Capital Management sold 208,733 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $647K.
EMC Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2020 and held it in 5 quarters.
EMC Capital Management's BioDelivery Sciences International, Inc. position peaked at $852K in Q3 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on EMC Capital Management's 13F filing for Q1 2022, filed 16 May 2022.